TRIB Earnings & Financial Statements
Trinity Biotech plc
$6.86
+$0.82(+13.49%)
34
Overall
40
Value
36
Tech
26
Quality
Market Cap
$5.57M
Volume
33.93K
52W Range
$5.01 - $52.50
Target Price
$15.00
TRIB earnings and financial statements: Trinity Biotech plc's income statement, balance sheet and cash flow statement, annual and quarterly.
TRIB Annual Financial Statements
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $61.55M | $56.83M | $62.52M | $92.97M | $101.98M |
| Cost of revenue | $40.11M | $37.38M | $45.25M | -$54.89M | -$53.40M |
| Operating income | -$19.76M | -$16.22M | -$11.26M | $1.80M | $16.00M |
| EBITDA | -$19.30M | -$24.38M | -$29.91M | $8.95M | $1.98M |
| Net income | -$31.79M | -$24.42M | -$41.01M | $875.0K | -$6.39M |
| EPS (diluted) | $-1.77 | $-3.14 | $-30.40 | $1.00 | $-195.00 |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total assets | $103.29M | $59.44M | $92.10M | $118.89M | $130.40M |
| Total liabilities | $138.47M | $83.38M | $90.55M | $119.21M | $132.62M |
| Shareholders’ equity | -$35.18M | -$23.95M | -$5.16M | $3.82M | $1.84M |
| Cash and equivalents | $5.17M | $3.69M | $6.58M | $25.91M | $24.21M |
| Long-term debt | $25.88M | $25.41M | $44.30M | - | $82.69M |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.19M | -$11.56M | -$921.0K | $13.24M | $23.75M |
| Capital expenditure | - | - | -$5.98M | -$8.69M | -$10.17M |
| Free cash flow | -$14.26M | -$14.26M | $34.11M | $4.55M | $13.59M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRIB | $6.86 | +13.5% | 33.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |